Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from UnitedHealth ( (UNH) ).
On June 2, 2025, UnitedHealth Group’s Board of Directors canceled performance-based restricted stock units for former CEO Andrew Witty following his retirement. During the same day, the company held its 2025 Annual Meeting of Shareholders, where nine directors were elected, executive compensation was approved, Deloitte & Touche LLP’s appointment was ratified, and a shareholder proposal on golden parachutes was rejected.
The most recent analyst rating on (UNH) stock is a Buy with a $647.00 price target. To see the full list of analyst forecasts on UnitedHealth stock, see the UNH Stock Forecast page.
Spark’s Take on UNH Stock
According to Spark, TipRanks’ AI Analyst, UNH is a Neutral.
UnitedHealth’s strong financial performance and reasonable valuation are overshadowed by bearish technical indicators and challenges detailed in the recent earnings call. The CEO transition adds uncertainty, though the company’s strategic growth focus provides some optimism. Investors should monitor the impact of increased care activity and member profile changes on future performance.
To see Spark’s full report on UNH stock, click here.
More about UnitedHealth
UnitedHealth Group Incorporated operates in the healthcare industry, offering a diverse range of health-related products and services. The company focuses on providing healthcare benefits and services through its various subsidiaries, aiming to improve health outcomes and reduce healthcare costs.
Average Trading Volume: 14,675,884
Technical Sentiment Signal: Sell
Current Market Cap: $276.4B
For detailed information about UNH stock, go to TipRanks’ Stock Analysis page.